Bridgefront Capital’s Vaxart VXRT Stock Holding History

Bridgefront Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,870	Closed	-$96K	–	682
2021 Q2	$96K	Buy	+12,870	New	+$89.9K	0.04%	555

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgefront Capital's VXRT Position: Q3 2021 in Review

Bridgefront Capital sold out of Vaxart (VXRT) in Q3 2021, closing a stake of 12,870 shares — an estimated $96K sold.

Bridgefront Capital first reported a position in VXRT in Q2 2021 and held it in 1 quarter. The position peaked at $96K in Q2 2021. 141 funds tracked by Wall St. Rank hold VXRT as of Q3 2021.

Bridgefront Capital reported no remaining Vaxart position as of Q3 2021 after selling out during the quarter.
Bridgefront Capital sold 12,870 Vaxart shares in Q3 2021, an estimated $96K.
Bridgefront Capital first reported a position in Vaxart in Q2 2021 and held it in 1 quarter.
Bridgefront Capital's Vaxart position peaked at $96K in Q2 2021.
141 funds tracked by Wall St. Rank held Vaxart as of Q3 2021.

Based on Bridgefront Capital's 13F filing for Q3 2021, filed 12 Nov 2021.